YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG: 1558)
Hong Kong
· Delayed Price · Currency is HKD 9.39
+0.04 (0.43%)
Nov 14, 2024, 4:08 PM HKT
YiChang HEC ChangJiang Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 1,648 | 1,993 | 76.6 | -587.65 | 839.46 | 1,919 | Upgrade
|
| Depreciation & Amortization | 395.33 | 391.27 | 377.36 | 259.82 | 122.73 | 86.19 | Upgrade
|
| Other Amortization | - | - | - | - | - | 3.65 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.53 | 0.53 | 0.82 | 19.07 | 5.27 | 4.83 | Upgrade
|
| Asset Writedown & Restructuring Costs | 485.39 | 485.39 | 288.84 | 25.98 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -4.39 | -4.39 | -522.7 | -19.24 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.03 | 0.03 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 45.14 | 45.14 | - | - | - | 3.19 | Upgrade
|
| Other Operating Activities | -714.63 | 165.06 | 1,084 | 136.21 | -446.26 | 177.67 | Upgrade
|
| Change in Accounts Receivable | -1,418 | -1,418 | -530.59 | -216.1 | 1,444 | -1,627 | Upgrade
|
| Change in Inventory | -94.02 | -94.02 | -35.33 | 98.57 | -185.95 | -28.04 | Upgrade
|
| Change in Accounts Payable | 109.49 | 109.49 | 961.31 | -379.18 | -479.79 | 1,255 | Upgrade
|
| Operating Cash Flow | 452.82 | 1,673 | 1,700 | -662.51 | 1,299 | 1,794 | Upgrade
|
| Operating Cash Flow Growth | -83.78% | -1.57% | - | - | -27.58% | 150.83% | Upgrade
|
| Capital Expenditures | -530.02 | -343.72 | -570.07 | -356.29 | -994.16 | -576.28 | Upgrade
|
| Sale of Property, Plant & Equipment | 6.32 | - | 0.95 | 0.03 | 19.62 | 4.54 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | -78.16 | Upgrade
|
| Sale (Purchase) of Intangibles | -321.08 | -251.36 | -283 | -223.4 | -923.88 | -1,097 | Upgrade
|
| Investment in Securities | 282.05 | 2,579 | -290 | - | - | - | Upgrade
|
| Other Investing Activities | 50.06 | -1,430 | 21.95 | 140.55 | -196.2 | 36.04 | Upgrade
|
| Investing Cash Flow | -512.68 | 554.57 | -1,120 | -439.11 | -2,095 | -1,710 | Upgrade
|
| Long-Term Debt Issued | - | 2,164 | 517.94 | 444.96 | 518.01 | 3,416 | Upgrade
|
| Long-Term Debt Repaid | - | -3,454 | -1,146 | -157.68 | -1.25 | -311.66 | Upgrade
|
| Total Debt Repaid | -3,591 | -3,454 | -1,146 | -157.68 | -1.25 | -311.66 | Upgrade
|
| Net Debt Issued (Repaid) | -2,047 | -1,290 | -628.22 | 287.28 | 516.76 | 3,104 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -136.92 | -245.96 | Upgrade
|
| Common Dividends Paid | - | - | - | - | -219.99 | -720.03 | Upgrade
|
| Other Financing Activities | -151.88 | -186.63 | -158.8 | -99.8 | -95.22 | -37.85 | Upgrade
|
| Financing Cash Flow | -2,199 | -1,477 | -787.03 | 187.48 | 64.63 | 2,100 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | -0.01 | -0.3 | 0.29 | -3.67 | 1.45 | Upgrade
|
| Net Cash Flow | -2,258 | 750.87 | -207.58 | -913.85 | -734.17 | 2,185 | Upgrade
|
| Free Cash Flow | -77.21 | 1,329 | 1,130 | -1,019 | 305.33 | 1,218 | Upgrade
|
| Free Cash Flow Growth | - | 17.67% | - | - | -74.93% | 1177.50% | Upgrade
|
| Free Cash Flow Margin | -1.39% | 21.12% | 30.17% | -111.49% | 13.00% | 19.57% | Upgrade
|
| Free Cash Flow Per Share | -0.09 | 1.51 | 1.28 | -1.16 | 0.28 | 1.21 | Upgrade
|
| Cash Interest Paid | 112.6 | 138.32 | 112.74 | 99.8 | 95.22 | 37.85 | Upgrade
|
| Cash Income Tax Paid | 369.16 | 230.49 | 255.43 | -18.62 | 303.73 | 341.15 | Upgrade
|
| Levered Free Cash Flow | -659.1 | 1,085 | -2,703 | -616.5 | -933.04 | -67.1 | Upgrade
|
| Unlevered Free Cash Flow | -568.48 | 1,228 | -2,527 | -464.12 | -780.41 | 57.06 | Upgrade
|
| Change in Net Working Capital | 1,494 | 357.61 | 2,253 | -142.07 | -493.85 | -59.64 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.